Literature DB >> 25758664

Absence of family history and phenotype-genotype correlation in pediatric Brugada syndrome: more burden to bear in clinical and genetic diagnosis.

Houria Daimi1, Amel Haj Khelil, Khaldoun Ben Hamda, Amelia Aranega, Jemni B E Chibani, Diego Franco.   

Abstract

Brugada syndrome (BrS) is an autosomal-dominant genetic cardiac disorder caused in 18-30 % of the cases by SCN5A gene mutations and manifested by an atypical right bundle block pattern with ST segment elevation and T wave inversion in the right precordial leads. The syndrome is usually detected after puberty. The identification of BrS in pediatric patients is thus a rare occurrence, and most of the reported cases are unmasked after febrile episodes. Usually, having a family history of sudden death represents the first reason to perform an ECG in febrile children. However, this practice makes the sporadic cases of cardiac disease and specially the asymptomatic ones excluded from this diagnosis. Here, we report a sporadic case of a 2-month-old male patient presented with vaccination-related fever and ventricular tachycardia associated with short breathing, palpitation and cold sweating. ECG changes were consistent with type 1 BrS. SCN5A gene analysis of the proband and his family revealed a set of mutations and polymorphisms differentially distributed among family members, however, without any clear genotype-phenotype correlation. Based on our findings, we think that genetic testing should be pursued as a routine practice in symptomatic and asymptomatic pediatric cases of BrS, with or without family history of sudden cardiac death. Similarly, our study suggests that pediatrician should be encouraged to perform an ECG profiling in suspicious febrile children and quickly manage fever since it is the most important factor unmasking BrS in children.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25758664     DOI: 10.1007/s00246-015-1133-5

Source DB:  PubMed          Journal:  Pediatr Cardiol        ISSN: 0172-0643            Impact factor:   1.655


  10 in total

1.  A connexin40 mutation associated with a malignant variant of progressive familial heart block type I.

Authors:  Naomasa Makita; Akiko Seki; Naokata Sumitomo; Halina Chkourko; Shigetomo Fukuhara; Hiroshi Watanabe; Wataru Shimizu; Connie R Bezzina; Can Hasdemir; Hideo Mugishima; Takeru Makiyama; Alban Baruteau; Estelle Baron; Minoru Horie; Nobuhisa Hagiwara; Arthur A M Wilde; Vincent Probst; Hervé Le Marec; Dan M Roden; Naoki Mochizuki; Jean-Jacques Schott; Mario Delmar
Journal:  Circ Arrhythm Electrophysiol       Date:  2012-01-13

2.  SCN5A mutations and the role of genetic background in the pathophysiology of Brugada syndrome.

Authors:  Vincent Probst; Arthur A M Wilde; Julien Barc; Frederic Sacher; Dominique Babuty; Philippe Mabo; Jacques Mansourati; Solena Le Scouarnec; Florence Kyndt; Cedric Le Caignec; Pascale Guicheney; Laetitia Gouas; Juliette Albuisson; Paola G Meregalli; Hervé Le Marec; Hanno L Tan; Jean-Jacques Schott
Journal:  Circ Cardiovasc Genet       Date:  2009-09-29

3.  Spectrum of pathogenic mutations and associated polymorphisms in a cohort of 44 unrelated patients with long QT syndrome.

Authors:  G Millat; P Chevalier; L Restier-Miron; A Da Costa; P Bouvagnet; B Kugener; L Fayol; C Gonzàlez Armengod; B Oddou; V Chanavat; E Froidefond; R Perraudin; R Rousson; C Rodriguez-Lafrasse
Journal:  Clin Genet       Date:  2006-09       Impact factor: 4.438

Review 4.  Genetics of cardiac arrhythmias.

Authors:  S Cummings; S Priori
Journal:  Minerva Med       Date:  2011-06       Impact factor: 4.806

5.  Human SCN5A gene mutations alter cardiac sodium channel kinetics and are associated with the Brugada syndrome.

Authors:  M B Rook; C Bezzina Alshinawi; W A Groenewegen; I C van Gelder; A C van Ginneken; H J Jongsma; M M Mannens; A A Wilde
Journal:  Cardiovasc Res       Date:  1999-12       Impact factor: 10.787

6.  The diagnostic and therapeutic aspects of loss-of-function cardiac sodium channelopathies in children.

Authors:  Priya Chockalingam; Sally-Ann B Clur; Johannes M P J Breur; Thomas Kriebel; Thomas Paul; Lukas A Rammeloo; Arthur A M Wilde; Nico A Blom
Journal:  Heart Rhythm       Date:  2012-08-08       Impact factor: 6.343

7.  Novel LQT-3 mutation affects Na+ channel activity through interactions between alpha- and beta1-subunits.

Authors:  R H An; X L Wang; B Kerem; J Benhorin; A Medina; M Goldmit; R S Kass
Journal:  Circ Res       Date:  1998-07-27       Impact factor: 17.367

8.  Right bundle branch block, persistent ST segment elevation and sudden cardiac death: a distinct clinical and electrocardiographic syndrome. A multicenter report.

Authors:  P Brugada; J Brugada
Journal:  J Am Coll Cardiol       Date:  1992-11-15       Impact factor: 24.094

Review 9.  Human genomics and its impact on arrhythmias.

Authors:  Dan M Roden
Journal:  Trends Cardiovasc Med       Date:  2004-04       Impact factor: 6.677

10.  Natural history of Brugada syndrome: insights for risk stratification and management.

Authors:  Silvia G Priori; Carlo Napolitano; Maurizio Gasparini; Carlo Pappone; Paolo Della Bella; Umberto Giordano; Raffaella Bloise; Carla Giustetto; Roberto De Nardis; Massimiliano Grillo; Elena Ronchetti; Giovanna Faggiano; Janni Nastoli
Journal:  Circulation       Date:  2002-03-19       Impact factor: 29.690

  10 in total
  3 in total

1.  Feasibility of analysis of the SCN5A gene in paraffin embedded samples in sudden infant death cases at the Pretoria Medico-Legal Laboratory, South Africa.

Authors:  Barbara Ströh van Deventer; Lorraine du Toit-Prinsloo; Chantal van Niekerk
Journal:  Forensic Sci Med Pathol       Date:  2018-06-16       Impact factor: 2.007

2.  Arrhythmic events in Brugada syndrome patients induced by fever.

Authors:  Gretje Roterberg; Ibrahim El-Battrawy; Michael Veith; Volker Liebe; Uzair Ansari; Siegfried Lang; Xiaobo Zhou; Ibrahim Akin; Martin Borggrefe
Journal:  Ann Noninvasive Electrocardiol       Date:  2019-11-20       Impact factor: 1.468

3.  Role of SCN5A coding and non-coding sequences in Brugada syndrome onset: What's behind the scenes?

Authors:  Houria Daimi; Amel Haj Khelil; Ali Neji; Khaldoun Ben Hamda; Sabri Maaoui; Amelia Aranega; Jemni Be Chibani; Diego Franco
Journal:  Biomed J       Date:  2019-09-12       Impact factor: 4.910

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.